AI tools are transforming cancer detection, significantly enhancing accuracy and treatment outcomes. One notable innovation is OmniPT, an AI-powered universal pathology assistant developed by Zhejiang University, now used at the First Affiliated Hospital of Zhejiang University School of Medicine. OmniPT improves cancer classification, tumor grading, and detection of vascular and neural invasion, with an 80-90% accuracy in predicting disease progression. Amidst a severe shortage of pathologists in China, this tool automates over 90% of repetitive tasks, allowing pathologists to focus on critical decisions. The integration of AI like OmniPT is essential for improving diagnostic efficiency and addressing workforce challenges in pathology.